Literature DB >> 11135346

Maximum likelihood inference for left-censored HIV RNA data.

H S Lynn1.   

Abstract

Left-censored data are characteristic of many bioassays due to inherent limit of detection and limit of quantitation (LOQ) in the assays. This paper examines how the left-censoring of plasma HIV RNA measurements, collected for the Hemophilia Growth and Development Study, affects the quantification of viral load and the assessment of its association with a continuous or dichotomous outcome. Data analyses using maximum likelihood estimation are compared to analyses where the LOQ or LOQ/2 value is substituted for the left-censored observations, and also to other methods like multiple imputation. A Gaussian distribution is assumed for the log-transformed plasma HIV RNA data, and simulations are used to explore the sensitivity of the results to changes in the model parameters. The robustness of the estimators is also investigated when the data are generated from a mixture of two Gaussian distributions. Maximum likelihood is in general the least biased method. However, multiple imputation assuming a censored Gaussian imputation model and substituting the censored values with the expectation of its conditional predictive distribution are also competitive to maximum likelihood, and may be appealing because of their simpler computational algorithms. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135346     DOI: 10.1002/1097-0258(20010115)20:1<33::aid-sim640>3.0.co;2-o

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  38 in total

1.  Lasso regularization for left-censored Gaussian outcome and high-dimensional predictors.

Authors:  Perrine Soret; Marta Avalos; Linda Wittkop; Daniel Commenges; Rodolphe Thiébaut
Journal:  BMC Med Res Methodol       Date:  2018-12-04       Impact factor: 4.615

2.  Organochlorine pesticides and endometriosis.

Authors:  Maureen A Cooney; Germaine M Buck Louis; Mary L Hediger; Albert Vexler; Paul J Kostyniak
Journal:  Reprod Toxicol       Date:  2010-05-16       Impact factor: 3.143

3.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.

Authors:  Nancie M Archin; Naveen K Vaidya; Joann D Kuruc; Abigail L Liberty; Ann Wiegand; Mary F Kearney; Myron S Cohen; John M Coffin; Ronald J Bosch; Cynthia L Gay; Joseph J Eron; David M Margolis; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

4.  Estimating correlation with multiply censored data arising from the adjustment of singly censored data.

Authors:  Elizabeth Newton; Ruthann Rudel
Journal:  Environ Sci Technol       Date:  2007-01-01       Impact factor: 9.028

5.  Flexible Modeling of Survival Data with Covariates Subject to Detection Limits via Multiple Imputation.

Authors:  Paul W Bernhardt; Huixia Judy Wang; Daowen Zhang
Journal:  Comput Stat Data Anal       Date:  2014-01       Impact factor: 1.681

6.  Estimating the odds ratio when exposure has a limit of detection.

Authors:  Stephen R Cole; Haitao Chu; Lei Nie; Enrique F Schisterman
Journal:  Int J Epidemiol       Date:  2009-08-10       Impact factor: 7.196

7.  Mental Health Care for Youth: Predictors of Use are not always the same as Predictors of Volume.

Authors:  Pierre K Alexandre
Journal:  Soc Sci J       Date:  2008-12

8.  Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit.

Authors:  Ryan E Wiegand; Charles E Rose; John M Karon
Journal:  Stat Methods Med Res       Date:  2014-05-05       Impact factor: 3.021

9.  Statistical Methods for Generalized Linear Models with Covariates Subject to Detection Limits.

Authors:  Paul W Bernhardt; Huixia J Wang; Daowen Zhang
Journal:  Stat Biosci       Date:  2015-05

Review 10.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.